Basis: Latest reported fiscal year. Source: stored company filings and market data; unavailable inputs remain N/A.
The forward PE ratio is 16.19 as of Thursday, July 30, 2026.
Forward PE Ratio (16.19) = Close Price ($240.96) / Consensus Forward EPS ($14.88)
FORWARD PE RATIO
16.19
SECTOR MEDIAN · HEALTHCARE
19.43
median of 68 covered companies
CURRENT VS SECTOR MEDIAN
-16.68%
vs the sector median at left
DaVita Inc.
Market Cap
$15.47B
Forward PE Ratio
16.19
| NAME | MARKET CAP | FORWARD PE RATIO |
|---|---|---|
| DaVita Inc. (DVA) | $15.47B | 16.19 |
| Solventum Corporation (SOLV)vs › | $15.33B | 13.52 |
| Medpace Holdings, Inc. (MEDP)vs › | $16.33B | 33.23 |
| The Cooper Companies, Inc. (COO)vs › | $14.25B | 15.77 |
| Hologic, Inc. (HOLX)vs › | $16.97B | 17.21 |
| Align Technology, Inc. (ALGN)vs › | $12.90B | 15.86 |
| Baxter International Inc. (BAX)vs › | $12.79B | 12.92 |
| Revvity, Inc. (RVTY)vs › | $12.65B | 21.63 |
| Zimmer Biomet Holdings, Inc. (ZBH)vs › | $18.79B | 11.45 |
| Insulet Corp. (PODD)vs › | $11.82B | 26.32 |
Trailing P/E
24.2
reported TTM EPS
Forward P/E
16.2
consensus next-FY EPS
The gap between the two multiples is the consensus growth expectation: analysts' forward EPS of $14.88 implies +49.7% EPS growth vs the reported trailing $9.94.
At today's $240.96 close, each upcoming fiscal year's consensus EPS implies a different multiple — how quickly the price is "paid down" by expected earnings if the estimates hold.
| Fiscal year end | Consensus EPS | Estimate range | Analysts | Implied P/E |
|---|---|---|---|---|
| 2026-12-31 | $14.88 | $14.33 – $15.83 | 5 | 16.2x |
| 2027-12-31 | $17.33 | $16.15 – $18.48 | 5 | 13.9x |
| 2028-12-31 | $19.16 | $18.26 – $20.07 | 2 | 12.6x |
Source: FMP analyst consensus estimates, refreshed with the daily precompute. "n/m" = the consensus EPS is not positive, so a multiple is undefined. There is no forward P/E history chart here because charting one would require the estimates as they stood in the past, which we do not store — see the trailing P/E history for how the realized multiple has moved.
PE Ratio = Share Price / Diluted EPS (TTM)
The price-to-earnings ratio measures how much investors pay for each dollar of trailing earnings. A lower PE can indicate a cheaper valuation; a higher PE implies higher growth expectations.
Expanded definitions: Investopedia, Wikipedia, Corporate Finance Institute
